Alector logo

Alector

Stock
Stock
ISIN: US0144421072
Ticker: ALEC
US0144421072
ALEC

Price

Price

CHART BY

Frequently asked questions

What is Alector's market capitalization?

The market capitalization of Alector is $182.16M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Alector?

Alector's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.709. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Alector's stock?

Currently, 10 analysts cover Alector's stock, with a consensus target price of $4.929. Analyst ratings provide insights into the stock's expected performance.

What is Alector's revenue over the trailing twelve months?

Over the trailing twelve months, Alector reported a revenue of $61.51M.

What is the EBITDA for Alector?

Alector's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$176.18M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Alector?

Alector has a free cash flow of -$222.26M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Alector have, and what sector and industry does it belong to?

Alector employs approximately 244 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

What is the free float of Alector's shares?

The free float of Alector is 75.59M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$182.16M
EPS (TTM) 
-$1.709
Free Float 
75.59M
Revenue (TTM) 
$61.51M
EBITDA (TTM) 
-$176.18M
Free Cashflow (TTM) 
-$222.26M

Pricing

1D span
$1.726$1.891
52W span
$1.73$8.82

Analyst Ratings

The price target is $4.929 and the stock is covered by 10 analysts.

Buy

6

Hold

2

Sell

2

Information

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Employees
244
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
US0144421072
Primary Ticker
ALEC

Knockouts

Join the conversation